Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$10.05 - $12.02 $1,095 - $1,310
-109 Reduced 9.84%
999 $10.6 Million
Q1 2024

Apr 16, 2024

BUY
$11.27 - $13.53 $12,487 - $14,991
1,108 New
1,108 $13.2 Million
Q3 2023

Oct 13, 2023

SELL
$9.59 - $11.35 $1,026 - $1,214
-107 Reduced 8.54%
1,146 $11.3 Million
Q2 2023

Aug 04, 2023

SELL
$9.02 - $10.29 $2,056 - $2,346
-228 Reduced 15.4%
1,253 $12.5 Million
Q1 2023

May 10, 2023

BUY
$9.2 - $12.26 $1,030 - $1,373
112 Added 8.18%
1,481 $14.2 Million
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $11,937 - $15,825
1,369 New
1,369 $15.2 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Register Financial Advisors LLC Portfolio

Follow Register Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Register Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Register Financial Advisors LLC with notifications on news.